AN2 Therapeutics Inc.

NASDAQ: ANTX · Real-Time Price · USD
1.06
-0.15 (-12.40%)
At close: May 30, 2025, 3:59 PM
1.10
3.77%
After-hours: May 30, 2025, 05:03 PM EDT

AN2 Therapeutics Revenue

AN2 Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, AN2 Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
22
Market Cap
31.99M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.